Anzeige
Mehr »
Login
Freitag, 18.10.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
5 Millionen Unzen und steigend: NexGold Mining's unerschlossene Goldstraße
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3C67T | ISIN: IT0005466963 | Ticker-Symbol: X7Q
Frankfurt
17.10.24
15:29 Uhr
3,700 Euro
+0,010
+0,27 %
Branche
Fahrzeuge
Aktienmarkt
Sonstige
1-Jahres-Chart
RACING FORCE SPA Chart 1 Jahr
5-Tage-Chart
RACING FORCE SPA 5-Tage-Chart
Actusnews Wire
293 Leser
Artikel bewerten:
(1)

Racing Force S.p.A.: Racing Force Group: revenue at EUR 37.6 million in 1H 2024 Revenues from core business keep growing again Positive order collection in the six months

Racing Force S.p.A., the parent company of Racing Force Group, which is specialized in the development, production, and marketing of safety components for motorsports worldwide, listed on the Euronext Growth segment in Milan (RFG) and Paris (ALRFG), announces consolidated sales figures for the 2024 first half, equal to €37.6 million, slightly better than the same period of previous year (+1% vs 1H 2023). The impact of exchange rate fluctuations in the six months compared to the previous fiscal year was negligible.

Excluding two seasonal orders for non-technical Racing Spirit branded apparel, 1H 2024 sales have grown compared to prior year (+4% vs 1H 2023). In addition, order collection in the six months confirms a mid-single-digit growth, as expected.

Compared to the previous fiscal year, the Group's sales mix in the first half of 2024 has been characterized by a different composition in terms of product categories.
In detail, sales of Driver's Equipment registered an increase of €0.7 million (+2.5%) compared to 2023 first half, driven by the growth of the OMP brand; turnover of Car Parts increased by €0.4 million (+5.4%), primarily due to supplies linked to the production programs of some main car manufacturers in Italy; the Other segment recorded a decrease of €0.7 million (-23.9%) due to non-technical Racing Spirit branded apparel sales made at the beginning of the previous fiscal year to two major clients for the entire season, which had a combined impact of over €1 million in 1H 2023.

In terms of geographical areas, all the major countries in the APAC region (Australia, China, and Japan) have recorded a significant growth compared to the same period in the previous fiscal year, totaling an overall increase of +13.2%. Sales in the EMEA region are slightly higher than 1H 2023 (+1.3%).
Turnover in the Americas for the first six months of the year is down 4.4% compared to 1H 2023, showing improvement from Q1, with a 4.5% increase in Q2 2024 compared to Q2 2023.
The variations in EMEA and the Americas were influenced by the aforementioned orders related to non-technical Racing Spirit branded apparel. Excluding these impacts, growth stands at +2.8% in EMEA and +3.3% in the Americas for the six months.

Dealers continue to represent the primary sales channel for the Group, accounting for 62% of total revenue in the first half of the year, slightly better than 1H 2023 (+0.5%), mainly due to the growth registered in Q2 2024 (+€0.3 million, equal to +3.4% compared to Q2 2023).
Revenue from Team & Car Manufacturers are overall up 3.2% compared to the first half of 2023 (+16.7% excluding the two Racing Spirit orders in 2023), following important technical partnership agreements signed by the Group in the major world championships and national competitions (including Nascar, in the United States), while sales to customers classified as Other are substantially aligned with the first half of 2023.

Paolo Delprato, Chief Executive Officer of Racing Force Group, commented: "Group sales in the first half of 2024 have increased compared to the previous year, particularly in the core business, thanks to higher revenue from racing suits and, more generally, from all OMP-branded products. Excluding non-technical apparel under the Racing Spirit brand, impacted by deliveries to two major clients at the beginning of 2023 for the entire season, revenue growth for the half-year is +4%.
In terms of geographic areas, it is noteworthy the continuous growth in Asia and the Pacific and the consolidation in Europe, where the Group has further confirmed its leadership position. In the Americas, there are positive signs of recovery, with a 4.5% increase in revenue in Q2 2024 compared to Q2 2023. The OMP brand alone has shown a 12% growth in the Americas in the first half, confirming our growth strategy.
All the diversification projects, particularly those in the defense helmet sector, are proceeding as expected".

------------------------
This publication embed "Actusnews SECURITY MASTER".
- SECURITY MASTER Key: xWieZ8qckmiZnZ6fastqnGeWnGaTx5PIZmiYm5Joa5qXmZxiyJmSa5iYZnFolWdn
- Check this key: https://www.security-master-key.com.
------------------------
Full and original release in PDF format:
https://www.actusnews.com/documents_communiques/ACTUS-0-87021-rfg-sales-1h-24.pdf

© Copyright Actusnews Wire
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
© 2024 Actusnews Wire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.